Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 360.60M
March 31, 2026 353.46M
December 31, 2025 524.17M
September 30, 2025 468.75M
June 30, 2025 261.67M
March 31, 2025 178.94M
December 31, 2024 302.02M
September 30, 2024 280.18M
June 30, 2024 321.52M
March 31, 2024 331.85M
December 31, 2023 276.73M
September 30, 2023 213.86M
June 30, 2023 202.92M
March 31, 2023 433.33M
December 31, 2022 408.33M
September 30, 2022 427.09M
June 30, 2022 457.37M
March 31, 2022 515.62M
December 31, 2021 568.27M
September 30, 2021 411.16M
June 30, 2021 400.83M
March 31, 2021 409.08M
December 31, 2020 274.45M
September 30, 2020 404.73M
June 30, 2020 358.64M
Date Value
March 31, 2020 324.25M
December 31, 2019 70.96M
September 30, 2019 218.38M
June 30, 2019 249.88M
March 31, 2019 289.96M
December 31, 2018 354.97M
September 30, 2018 374.98M
June 30, 2018 388.59M
March 31, 2018 403.56M
December 31, 2017 416.70M
September 30, 2017 383.84M
June 30, 2017 354.74M
March 31, 2017 295.77M
December 31, 2016 269.51M
September 30, 2016 189.33M
June 30, 2016 224.29M
March 31, 2016 148.67M
December 31, 2015 154.04M
September 30, 2015 184.63M
June 30, 2015 191.93M
March 31, 2015 231.10M
December 31, 2014 159.20M
September 30, 2014 40.07M
June 30, 2014 55.55M
March 31, 2014 76.59M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Evaxion AS 14.00M
Genmab A/S 1.503B
Ascendis Pharma A/S 928.66M
Zealand Pharma A/S 2.211B
Agenus, Inc. 18.74M